• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯胺酮与国际法规。

Ketamine and international regulations.

作者信息

Liao Yanhui, Tang Yi-Lang, Hao Wei

机构信息

a Mental Health Institute of the Second Xiangya Hospital, Central South University, The China National Clinical Research Center for Mental Health Disorders, National Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province , Changsha , Hunan , China.

b Department of Psychiatry and Biobehavioral Sciences , UCLA , Los Angeles , CA , USA.

出版信息

Am J Drug Alcohol Abuse. 2017 Sep;43(5):495-504. doi: 10.1080/00952990.2016.1278449. Epub 2017 Feb 13.

DOI:10.1080/00952990.2016.1278449
PMID:28635347
Abstract

BACKGROUND

Ketamine is an anesthetic commonly used in low-income countries and has recently been shown to be effective for treatment-resistant depression. However, the illicit manufacturing, trafficking, and nonmedical use of ketamine are increasing globally, and its illicit use poses major public health challenges in many countries.

OBJECTIVES

To review the nonmedical use of ketamine in selected countries and its regulatory control.

METHODS

We conducted a review of literature identified from searches of the China National Knowledge Infrastructure (CNKI) (1979-2016) and PubMed databases, supplemented by additional references identified by the authors. Special attention was given to the regulation of ketamine.

RESULTS

Illicit manufacturing, trafficking, and use of ketamine appear to have begun on a large scale in several Asian nations, and it has subsequently spread to other regions. Regulations governing availability of ketamine vary across countries, but there is a clear trend toward tighter regulations.

CONCLUSIONS

As nonmedical use of ketamine and its harmful consequences have worsened globally, stricter controls are necessary. Appropriate regulation of ketamine is important for international efforts to control ketamine's cross-border trafficking and its nonmedical use.

摘要

背景

氯胺酮是低收入国家常用的一种麻醉剂,最近已被证明对难治性抑郁症有效。然而,氯胺酮的非法制造、贩运和非医疗用途在全球范围内不断增加,其非法使用在许多国家构成了重大的公共卫生挑战。

目的

回顾选定国家氯胺酮的非医疗用途及其监管控制情况。

方法

我们对通过检索中国知网(CNKI)(1979 - 2016年)和PubMed数据库确定的文献进行了综述,并补充了作者找到的其他参考文献。特别关注了氯胺酮的监管情况。

结果

氯胺酮的非法制造、贩运和使用似乎在几个亚洲国家大规模开始,随后蔓延到其他地区。各国对氯胺酮可得性的监管各不相同,但有明显的收紧监管趋势。

结论

由于氯胺酮的非医疗用途及其有害后果在全球范围内恶化,有必要进行更严格的管控。对氯胺酮进行适当监管对于国际上控制氯胺酮跨境贩运及其非医疗用途的努力至关重要。

相似文献

1
Ketamine and international regulations.氯胺酮与国际法规。
Am J Drug Alcohol Abuse. 2017 Sep;43(5):495-504. doi: 10.1080/00952990.2016.1278449. Epub 2017 Feb 13.
2
Access to controlled medicines for anesthesia and surgical care in low-income countries: a narrative review of international drug control systems and policies.低收入国家获取用于麻醉和手术护理的管制药品:对国际药物管制系统和政策的叙述性综述
Can J Anaesth. 2017 Mar;64(3):296-307. doi: 10.1007/s12630-016-0805-9. Epub 2017 Jan 3.
3
Importance of ketamine.氯胺酮的重要性。
Vet Rec. 2016 Mar 12;178(11):271. doi: 10.1136/vr.i1410.
4
Ketamine for Chronic Pain and Mental Health: Regulations, Legalities, and the Growth of Infusion Clinics.氯胺酮治疗慢性疼痛和精神健康:法规、合法性和输注诊所的发展。
Curr Pain Headache Rep. 2023 Oct;27(10):579-585. doi: 10.1007/s11916-023-01150-1. Epub 2023 Aug 12.
5
Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia.氯胺酮麻醉在电抽搐治疗难治性抑郁症中的快速抗抑郁作用:比较氯胺酮和丙泊酚麻醉。
J ECT. 2010 Sep;26(3):223-7. doi: 10.1097/YCT.0b013e3181c3b0aa.
6
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
7
Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.5-羟色胺能信号系统在氯胺酮抗抑郁作用中的潜在作用:一项批判性评价。
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Nov 3;71:27-38. doi: 10.1016/j.pnpbp.2016.05.007. Epub 2016 Jun 2.
8
Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.氯胺酮作为快速抗抑郁药的超说明书重复处方是否安全?争议、伦理问题及法律影响。
BMC Med Ethics. 2016 Jan 14;17:4. doi: 10.1186/s12910-016-0087-3.
9
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.锂盐和丙戊酸盐水平与氯胺酮在难治性双相抑郁中的抗抑郁疗效不相关。
Neural Plast. 2015;2015:858251. doi: 10.1155/2015/858251. Epub 2015 Jun 7.
10
What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.氯胺酮快速起效的抗抑郁作用机制是什么?对大量惊人可能性的简要概述。
J Clin Pharm Ther. 2017 Apr;42(2):147-154. doi: 10.1111/jcpt.12497. Epub 2017 Jan 22.

引用本文的文献

1
Safety considerations and risk mitigation strategies for ketamine use: a comprehensive review.氯胺酮使用的安全性考量与风险缓解策略:一项全面综述
Ann Med Surg (Lond). 2025 Apr 2;87(5):2829-2837. doi: 10.1097/MS9.0000000000003232. eCollection 2025 May.
2
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotheray for methamphetamine use disorder (the KAPPA trial).氯胺酮辅助心理治疗甲基苯丙胺使用障碍的开放标签安全性和可行性初步研究方案(KAPPA试验)
BMJ Open. 2025 Feb 10;15(2):e092504. doi: 10.1136/bmjopen-2024-092504.
3
Examining memory reconsolidation as a mechanism of nitrous oxide's antidepressant action.
研究记忆重新巩固作为一氧化二氮抗抑郁作用的一种机制。
Neuropsychopharmacology. 2025 Mar;50(4):609-617. doi: 10.1038/s41386-024-02049-0. Epub 2025 Jan 17.
4
Widespread reductions in cortical thickness following ketamine abuse.广泛的皮质厚度减少后,滥用氯胺酮。
J Psychiatry Neurosci. 2024 May 30;49(3):E182-E191. doi: 10.1503/jpn.230111. Print 2024 May-Jun.
5
The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews. scheduling 氯胺酮作为一种国际管制物质对撒哈拉以南非洲地区麻醉护理的影响:案例研究和关键知情人访谈。
BMC Health Serv Res. 2024 May 7;24(1):598. doi: 10.1186/s12913-024-11040-w.
6
NMDA Receptor Glycine Binding Site Modulators for Prevention and Treatment of Ketamine Use Disorder.用于预防和治疗氯胺酮使用障碍的N-甲基-D-天冬氨酸受体甘氨酸结合位点调节剂
Pharmaceuticals (Basel). 2023 May 30;16(6):812. doi: 10.3390/ph16060812.
7
The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?谷氨酸能系统在治疗抵抗性抑郁症中的作用和氯胺酮与艾司氯胺酮的比较疗效:炎症的作用?
Adv Exp Med Biol. 2023;1411:487-512. doi: 10.1007/978-981-19-7376-5_21.
8
Features of Psychotic Symptoms in Methamphetamine Use Disorder Patients and Ketamine Use Disorder Patients: A Cross-Sectional Study.甲基苯丙胺使用障碍患者和氯胺酮使用障碍患者的精神病性症状特征:一项横断面研究。
Front Psychiatry. 2022 Jan 18;12:786622. doi: 10.3389/fpsyt.2021.786622. eCollection 2021.
9
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?氯胺酮在抑郁症及相关疾病中的新用途:这种神秘药物能否取得成功?
Front Neurosci. 2021 Apr 30;15:657714. doi: 10.3389/fnins.2021.657714. eCollection 2021.
10
Interpol review of controlled substances 2016-2019.国际刑警组织2016 - 2019年受管制物质审查
Forensic Sci Int Synerg. 2020 May 24;2:608-669. doi: 10.1016/j.fsisyn.2020.01.019. eCollection 2020.